Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2018 - 2025)
Historic Depreciation & Amortization (CF) for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $5600.0.
- Whitehawk Therapeutics' Depreciation & Amortization (CF) fell 8800.86% to $5600.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $131900.0, marking a year-over-year decrease of 3068.84%. This contributed to the annual value of $193000.0 for FY2024, which is 1420.12% up from last year.
- As of Q3 2025, Whitehawk Therapeutics' Depreciation & Amortization (CF) stood at $5600.0, which was down 8800.86% from $15300.0 recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Depreciation & Amortization (CF) registered a high of $74000.0 during Q1 2022, and its lowest value of $2000.0 during Q1 2021.
- Over the past 5 years, Whitehawk Therapeutics' median Depreciation & Amortization (CF) value was $44000.0 (recorded in 2023), while the average stood at $37431.6.
- In the last 5 years, Whitehawk Therapeutics' Depreciation & Amortization (CF) soared by 360000.0% in 2022 and then crashed by 8800.86% in 2025.
- Whitehawk Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $72000.0 in 2021, then crashed by 36.11% to $46000.0 in 2022, then decreased by 4.35% to $44000.0 in 2023, then rose by 22.73% to $54000.0 in 2024, then plummeted by 89.63% to $5600.0 in 2025.
- Its Depreciation & Amortization (CF) stands at $5600.0 for Q3 2025, versus $15300.0 for Q2 2025 and $57000.0 for Q1 2025.